The Synoptics Health division of the Synoptics Group focuses on imaging techniques within the clinical environment.
Synoptics has been successfully developing and supplying imaging solutions to life science researchers across the globe since 1986. The new Synoptics Health division is currently utilising that expertise to provide a patented fluorescence protein detection system, which has been developed over four years in partnership with Queen Mary University of London (QMUL).
No reviews to display
Synoptics Health’s ProReveal Protein Detection Test Helps Serchem Rapidly Optimize Detergent Chemistries to Meet Decontamination Regulations
27 Nov 2013
MP to Visit Synoptics Health In Support of New Technology to Revolutionize Testing of Decontaminated Surgical Instruments
21 Aug 2013
24 Jul 2013
Study in UK SSDs of ProReveal Fluorescence Protein Detection Test Shows Technology can Detect Nanogram Amounts of Protein on Surgical Instruments
29 Nov 2012
26 Nov 2012